Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials.
Jennifer L LundJenna CacciatoreRachael G TylockI-Hsuan SuSaloni SharmaSharon Peacock HintonSabirah SmithMolly A NowelsXiaomeng Chen MsphPaul R DubersteinLaura C HansonSupriya G MohilePublished in: JCO clinical cancer informatics (2024)
Extending clinical trial mortality follow-up through linkage with external data sources was feasible and accurate. Future cancer clinical trials should collect necessary consent and patient identifiers for vital status linkages that can enhance understanding of longer-term outcomes.
Keyphrases
- clinical trial
- advanced cancer
- palliative care
- cardiovascular events
- phase ii
- papillary thyroid
- risk factors
- case report
- electronic health record
- drinking water
- preterm infants
- open label
- physical activity
- squamous cell
- type diabetes
- genome wide
- big data
- coronary artery disease
- high resolution
- community dwelling
- gene expression
- current status
- randomized controlled trial
- study protocol
- dna methylation
- machine learning
- phase iii
- young adults
- gestational age
- metabolic syndrome
- artificial intelligence
- lymph node metastasis
- hepatitis c virus
- insulin resistance
- weight loss
- childhood cancer
- glycemic control
- men who have sex with men
- data analysis